MDNA
Medicenna Therapeutics Corp. Common Shares
MDNA
MDNA
Delisted
MDNA was delisted on the 1st of November, 2023.
20 hedge funds and large institutions have $5.55M invested in Medicenna Therapeutics Corp. Common Shares in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
20
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$85K | |
| 2 | +$77K | |
| 3 | +$74.7K | |
| 4 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$74.3K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$26K |
Top Sellers
| 1 | -$453K | |
| 2 | -$110K | |
| 3 | -$76.2K | |
| 4 |
KJHP
K.J. Harrison & Partners
Toronto,
Ontario, Canada
|
-$17K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$8K |